1-[4-(3,4-difluorophenoxy)phenyl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one
C24H22F2N4O3S — CID 122653895
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(3,4-difluorophenoxy)phenyl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one
1-[4-(3,4-difluorophenoxy)phenyl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one (PubChem CID 122653895) has the molecular formula C24H22F2N4O3S and a molecular weight of 484.53 g/mol. Its IUPAC name is 1-[4-(3,4-difluorophenoxy)phenyl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one.
Molecular Properties
| Compound Name | 1-[4-(3,4-difluorophenoxy)phenyl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one |
|---|---|
| PubChem CID | 122653895 |
| Molecular Formula | C24H22F2N4O3S |
| Molecular Weight | 484.53 g/mol |
| Exact Mass | 484.14 |
| IUPAC Name | 1-[4-(3,4-difluorophenoxy)phenyl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one |
| SMILES | O=C(c1nccs1)N1CCN(C2CC(=O)N(c3ccc(Oc4ccc(F)c(F)c4)cc3)C2)CC1 |
| InChI | InChI=1S/C24H22F2N4O3S/c25-20-6-5-19(14-21(20)26)33-18-3-1-16(2-4-18)30-15-17(13-22(30)31)28-8-10-29(11-9-28)24(32)23-27-7-12-34-23/h1-7,12,14,17H,8-11,13,15H2 |
| InChIKey | AJWFQTWBAHAYAW-UHFFFAOYSA-N |
| XLogP | 3.78 |
| TPSA | 65.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 484.53 |
| LogP ≤ 5 | 3.78 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122653895 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.